A Single-arm, Open-lable, Multicenter, Phase II Clinical Study of HX008 in Subjects With BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Latest Information Update: 06 Dec 2023
At a glance
- Drugs Pucotenlimab (Primary)
- Indications Bladder cancer; Carcinoma; Urogenital cancer
- Focus Therapeutic Use
- Sponsors Taizhou Hanzhong Pharmaceuticals
- 05 Feb 2021 New trial record